The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A Risk Prediction Score for Kidney Failure or Mortality in Rhabdomyolysis
Open accessAbstract
IMPORTANCE: Rhabdomyolysis ranges in severity from asymptomatic elevations in creatine phosphokinase levels to a life-threatening disorder characterized by severe acute kidney injury requiring hemodialysis or continuous renal replacement therapy (RRT). OBJECTIVE: To develop a risk prediction tool to identify patients at greatest risk of RRT or in-hospital mortality. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of 2371 patients admitted between January 1, 2000, and March 31, 2011, to 2 large teaching hospitals in Boston, Massachusetts, with creatine phosphokinase levels in excess of 5000 U/L within 3 days of admission. The derivation cohort consisted of 1397 patients from Massachusetts General Hospital, and the validation cohort comprised 974 patients from Brigham and Women's Hospital. MAIN OUTCOMES AND MEASURES: The composite of RRT or in-hospital mortality. RESULTS: The causes and outcomes of rhabdomyolysis were similar between the derivation and validation cohorts. In total, the composite outcome occurred in 19.0% of patients (8.0% required RRT and 14.1% died during hospitalization). The highest rates of the composite outcome were from compartment syndrome (41.2%), sepsis (39.3%), and following cardiac arrest (58.5%). The lowest rates were from myositis (1.7%), exercise (3.2%), and seizures (6.0%). The independent predictors of the composite outcome were age, female sex, cause of rhabdomyolysis, and values of initial creatinine, creatine phosphokinase, phosphate, calcium, and bicarbonate. We developed a risk-prediction score from these variables in the derivation cohort and subsequently applied it in the validation cohort. The C statistic for the prediction model was 0.82 (95% CI, 0.80-0.85) in the derivation cohort and 0.83 (0.80-0.86) in the validation cohort. The Hosmer-Lemeshow P values were .14 and .28, respectively. In the validation cohort, among the patients with the lowest risk score (<5), 2.3% died or needed RRT. Among the patients with the highest risk score (>10), 61.2% died or needed RRT. CONCLUSIONS AND RELEVANCE: Outcomes from rhabdomyolysis vary widely depending on the clinical context. The risk of RRT or in-hospital mortality in patients with rhabdomyolysis can be estimated using commonly available demographic, clinical, and laboratory variables on admission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
Khwaja, A. (2012) · Nephron Clinical Practice · doi:10.1159/000339789 · Cited by 8,014
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.1 · Cited by 4,326
Rhabdomyolysis and Acute Kidney Injury
Bosch, X., Poch, E., & Grau, J. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801327 · Cited by 1,488
MEHRAN, R., AYMONG, E., NIKOLSKY, E., LASIC, Z., IAKOVOU, I., FAHY, M., MINTZ, G., LANSKY, A., MOSES, J., & STONE, G. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)01445-7 · Cited by 1,251
The Spectrum of Rhabdomyolysis
GABOW, P. A., KAEHNY, W. D., & KELLEHER, S. P. (1982) · Medicine · doi:10.1097/00005792-198205000-00002 · Cited by 1,078
Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Melli, G., Chaudhry, V., & Cornblath, D. R. (2005) · Medicine · doi:10.1097/01.md.0000188565.48918.41 · Cited by 629
Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review
Minne, L., Abu-Hanna, A., & de Jonge, E. (2008) · Critical Care · doi:10.1186/cc7160 · Cited by 547
Wijeysundera, D. N., Karkouti, K., Dupuis, J.-Y., Rao, V., Chan, C. T., Granton, J. T., & Beattie, W. S. (2007) · JAMA · doi:10.1001/jama.297.16.1801 · Cited by 469
Factors Predictive of Acute Renal Failure in Rhabdomyolysis
Ward, M. M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.7.1553 · Cited by 464
Waikar, S. S., Wald, R., Chertow, G. M., Curhan, G. C., Winkelmayer, W. C., Liangos, O., Sosa, M.-A., & Jaber, B. L. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010073 · Cited by 460
Self-citationSerum Creatine Kinase Levels and Renal Function Measures in Exertional Muscle Damage
CLARKSON, P. M., KEARNS, A. K., ROUZIER, P., RUBIN, R., & THOMPSON, P. D. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000210192.49210.fc · Cited by 314
Peres Bota, D., Melot, C., Lopes Ferreira, F., Nguyen Ba, V., & Vincent, J.-L. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1491-3 · Cited by 279
de Meijer, A. R., Fikkers, B. G., de Keijzer, M. H., van Engelen, B. G. M., & Drenth, J. P. H. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1800-5 · Cited by 275
Rhee, C. M. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.677 · Cited by 222
ACTN3 and MLCK genotype associations with exertional muscle damage
Clarkson, P. M., Hoffman, E. P., Zambraski, E., Gordish-Dressman, H., Kearns, A., Hubal, M., Harmon, B., & Devaney, J. M. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00130.2005 · Cited by 217
Hypocalcemia and Hypercalcemia in Patients with Rhabdomyolysis with and without Acute Renal Failure*
AKMAL, M., Bishop, J. E., Telfer, N., Norman, A. W., & Massry, S. G. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-1-137 · Cited by 133
CM-MM and ACE genotypes and physiological prediction of the creatine kinase response to exercise
Heled, Y., Bloom, M. S., Wu, T. J., Stephens, Q. C., & Deuster, P. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00081.2007 · Cited by 114
Ho, K. M., Lee, K. Y., Williams, T. A., Finn, J., Knuiman, M. W., & Webb, S. A. R. (2007) · Anaesthesia · doi:10.1111/j.1365-2044.2007.04999.x · Cited by 107
Increasing Creatine Kinase Concentrations at the 161-km Western States Endurance Run
Hoffman, M. D., Ingwerson, J. L., Rogers, I. R., Hew‐Butler, T., & Stuempfle, K. J. (2012) · Wilderness and Environmental Medicine · doi:10.1016/j.wem.2011.11.001 · Cited by 96
CCL2 and CCR2 polymorphisms are associated with markers of exercise-induced skeletal muscle damage
Hubal, M. J., Devaney, J. M., Hoffman, E. P., Zambraski, E. J., Gordish‐Dressman, H., Kearns, A. K., Larkin, J. S., Adham, K., Patel, R. R., & Clarkson, P. M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00361.2009 · Cited by 93
Cited by
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., Susantitaphong, P., Rocco, M., Vanholder, R., Sever, M. S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60126-x · Cited by 1,154
Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice
Chavez, L. O., Leon, M., Einav, S., & Varon, J. (2016) · Critical Care · doi:10.1186/s13054-016-1314-5 · Cited by 476
Calibration drift in regression and machine learning models for acute kidney injury
Davis, S. E., Lasko, T. A., Chen, G., Siew, E. D., & Matheny, M. E. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx030 · Cited by 312
Sutherland, S. M., Chawla, L. S., Kane-Gill, S. L., Hsu, R. K., Kramer, A. A., Goldstein, S. L., Kellum, J. A., Ronco, C., Bagshaw, S. M., & on behalf of the 15 ADQI Consensus Group (2016) · Canadian Journal of Kidney Health and Disease · doi:10.1186/s40697-016-0099-4 · Cited by 115
Metadata
- Authors
- McMahon, G. M., Zeng, X., & Waikar, S. S.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2013-10-28
- Volume
- 173
- Issue
- 19
- Pages
- 1821
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2151444324
- Cited by
- 323
- References
- 20
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.